Skip to main content

Table 5 FM patients with post-COVID-19. Evolution of the severity of FM before and after COVID-19 in those patients from the ICAF cohort with concomitant PC

From: Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseases

 

Before

COVID-19

After

COVID-19

ANOVA

Mean

(SD)a

Mean

(SD)a

Fb

DFc

p

ICAFd

 Total

48.76

(10.31)

53.29

(9.39)

6.99

1,25

0.014

 Physical factor

50.45

(10.83)

56.81

(8.30)

10.92

1,25

0.003

 Emotional factor

48.39

(10.07)

51.14

(9.50)

3.94

1,25

0.058

 Active coping

52.50

(9.92)

50.64

(11.49)

0.74

1,25

0.398

 Passive coping

51.34

(10.55)

53.56

(12.69)

0.88

1,25

0.357

ACRe criteria

 WPIf

12.90

(3.61)

13.76

(3.54)

2.08

1,28

0.160

 SSSg

9.14

(2.73)

9.00

(2.39)

0.04

1,28

0.745

 PSDh

22.03

(5.60)

22.76

(5.48)

0.73

1,28

0.398

  1. a SD Standard deviation. b F value. c DF Degree of freedom. d ICAF Combined Index of Severity of Fibromyalgia. e ACR American College of Rheumatology criteria. f WPI Widespread Pain Index. g SSS Symptoms Severity Scale. h PSD Polysymptomatic Distress Scale